The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.
about
Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline.Contemporary Management of 1-4 Brain MetastasesBrain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients
P2860
The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The risk of radiation necrosis ...... concurrent systemic therapies.
@en
The risk of radiation necrosis ...... concurrent systemic therapies.
@nl
type
label
The risk of radiation necrosis ...... concurrent systemic therapies.
@en
The risk of radiation necrosis ...... concurrent systemic therapies.
@nl
prefLabel
The risk of radiation necrosis ...... concurrent systemic therapies.
@en
The risk of radiation necrosis ...... concurrent systemic therapies.
@nl
P2093
P2860
P1476
The risk of radiation necrosis ...... concurrent systemic therapies.
@en
P2093
Aditya Juloori
Alireza M Mohammadi
David M Peereboom
Erin S Murphy
Glen H Stevens
Jacob A Miller
John H Suh
Joseph M Kim
Lilyana Angelov
Manmeet S Ahluwalia
P2860
P2888
P304
P356
10.1007/S11060-017-2442-8
P577
2017-04-22T00:00:00Z